Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer.

Breast Cancer · 2019 · PMC6694038 · PMID 30734152

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Smoking status ( p = 0.07) and the CYP2C19 phenotype ( p = 0.07), but not the CYP2D6 genotype ( p = 0.61), showed marginally significant effects on TOR activity.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.